EP 0563209 A1 19931006 - USE OF HIRUDINE AND ITS MUTEINES AND THEIR PEG DERIVATIVES FOR THE COMBINED TREATMENT OF TUMOURS.
Title (en)
USE OF HIRUDINE AND ITS MUTEINES AND THEIR PEG DERIVATIVES FOR THE COMBINED TREATMENT OF TUMOURS.
Title (de)
VERWENDUNG VON HIRUDIN UND DESSEN MUTEINEN SOWIE DEREN PEG-DERIVATEN ZUR KOMBINATIONSBEHANDLUNG VON TUMOREN.
Title (fr)
UTILISATION D'HIRUDINE ET DE SES MUTEINES AINSI QUE DE LEURS DERIVES PEG POUR LE TRAITEMENT COMBINATOIRE DE TUMEURS.
Publication
Application
Priority
DE 4041185 A 19901221
Abstract (en)
[origin: DE4041185A1] The description relates to the use of hirudine and its muteines and their PEG derivatives for the production of medicaments in the treatment of tumours.
Abstract (fr)
Il est décrit l'utilisation d'hirudine et de ses mutéines ainsi que de leurs dérivés PEG pour la fabrication de médicaments servant à la lutte contre les tumeurs.
IPC 1-7
IPC 8 full level
A61K 38/55 (2006.01); A61K 38/58 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 38/58 (2013.01); A61P 35/00 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 9211024A1
Designated contracting state (EPC)
AT BE CH DE DK FR GB IT LI NL SE
DOCDB simple family (publication)
DE 4041185 A1 19920625; CA 2098707 A1 19920622; EP 0563209 A1 19931006; JP H06503819 A 19940428; WO 9211024 A1 19920709
DOCDB simple family (application)
DE 4041185 A 19901221; CA 2098707 A 19911210; EP 9102361 W 19911210; EP 92901972 A 19911210; JP 50098691 A 19911210